BOULDER, Colo. (AP) _ Nivalis Therapeutics Inc. (NVLS) on Monday reported a loss of $7.7 million in its fourth quarter.
On a per-share basis, the Boulder, Colorado-based company said it had a loss of 50 cents.
The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 55 cents per share.
For the year, the company reported that its loss widened to $31.5 million, or $2.03 per share.
The company's shares closed at $2.37. A year ago, they were trading at $4.48.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NVLS at https://www.zacks.com/ap/NVLS
Keywords: Nivalis Therapeutics, Earnings Report